Fundraising FoxAradigm Corporation
1 known investors
Find your way into Aradigm Corporation
Sign up to find every way you can get introduced to Aradigm Corporation
- Your email: who you already know at Aradigm Corporation, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Aradigm Corporation team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Developer of advanced pulmonary drug delivery systems for systemic conditions and lung diseases
Investors · 1
Non-dilutive funding · 7 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $972.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $339.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $277.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2005 | $153.2K |
| U.S. ArmyArmy | Phase I | 2003 | $70K |
| Department of Health and Human Services | Phase II | 1998 | $750K |
| Department of Health and Human Services | Phase I | 1997 | $99.8K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Aradigm Corporation do?
- Developer of advanced pulmonary drug delivery systems for systemic conditions and lung diseases
- Who are Aradigm Corporation's investors?
- Aradigm Corporation's investors include Camden Partners.